PLXS (Plexus) Change In Receivables: $-111 Mil (TTM As of Mar. 2026)

Plexus PLXS -1.22% 78 Change In Receivables is $-111 Mil as of Mar. 2026. GuruFocus rates PLXS with a GF Score™ of 78/100 and a GF Value™ of $149.69 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Plexus's change in receivables for the quarter that ended in Mar. 2026 was $-32 Mil. It means Plexus's Accounts Receivable increased by $32 Mil from Dec. 2025 to Mar. 2026 .

Plexus's change in receivables for the fiscal year that ended in Sep. 2025 was $-60 Mil. It means Plexus's Accounts Receivable increased by $60 Mil from Sep. 2024 to Sep. 2025 .

Plexus's Accounts Receivable for the quarter that ended in Mar. 2026 was $702 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Plexus's Days Sales Outstanding for the three months ended in Mar. 2026 was 55.07.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Plexus's liquidation value for the three months ended in Mar. 2026 was $-354 Mil.

Plexus (NAS:PLXS) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Plexus's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	702.339	/	1163.757	*	91
=	55.07

2. In Ben Graham's calculation of liquidation value, Plexus's accounts receivable are only considered to be worth 75% of book value:

Plexus's liquidation value for the quarter that ended in Mar. 2026 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	303.133	-	1871.169	+	0.75 * 702.339	+	0.5 * 1373.732
=	-354

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Plexus Change In Receivables Related Terms

Plexus Change In Receivables Historical Data

* Premium members only.

The historical data trend for Plexus's Change In Receivables can be seen below:

Plexus Change In Receivables Chart

Plexus Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Sep25

Change In Receivables

Get a 7-Day Free Trial

-34.86

-253.47

78.37

66.65

-60.43

Plexus Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Change In Receivables	Get a 7-Day Free Trial															-16.41	-54.83	0.93	-24.86	-32.24

78GF Score

Plexus Corp PLXS

Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Plexus Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-111 Mil.

Frequently Asked Questions Learn more about Change In Receivables →

What does a Change In Receivables of $-111 Mil mean?

Plexus (PLXS) has a Change In Receivables of $-111 Mil as of Mar. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Plexus and its competitors.

Is Plexus' Change In Receivables too high?

Plexus' current Change In Receivables is $-111 Mil. Overall, Plexus has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Plexus' Change In Receivables compare to RAL and BELFB?

Plexus' Change In Receivables of $-111 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Change In Receivables for a Hardware company?

A good Change In Receivables depends on the Hardware industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Change In Receivables mean?

A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Plexus and its competitors. Plexus's current Change In Receivables is $-111 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Plexus stock overvalued right now?

Based on GuruFocus' analysis, Plexus (PLXS) is currently considered Significantly Overvalued. The stock's GF Value™ is $149.69, compared to a current price of $267.27 — trading 78.5% above its estimated fair value. The current Change In Receivables is $-111 Mil. Plexus' overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Change In Receivables calculated?

Change In Receivables is calculated from a company's financial statements. For Plexus (PLXS), the current Change In Receivables is $-111 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Plexus (PLXS) Overvalued in 2026?

Based on GuruFocus' analysis, Plexus stock appears to be overvalued. The current stock price of $267.27 is trading 78.5% above its estimated GF Value™ of $149.69. GuruFocus considers Plexus to be Significantly Overvalued.

Key valuation signals for PLXS:

Change In Receivables: $-111 Mil
GF Value™: $149.69 vs. price of $267.27 (78.5% above fair value)
GF Score™: 78/100 with 2 warning signs

No single metric tells the full story. See the PLXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Plexus Business Description

Industry Technology Hardware

Comparable Companies RAL BELFB OLED LFUS OSIS KN BHE ROG SANM OUST APH GLW TPE:2308 TSE:6981 TPE:2317 XKRX:009150 SZSE:002475 SZSE:002384 TPE:2327 SHSE:600183

Other Exchanges PX4:Germany

Address One Plexus Way, P.O. Box 156, Neenah, WI, USA, 54956

Website https://www.plexus.com

Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.

78GF Score

Get the complete analysis for PLXS

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$267.27

Price

$149.69

GF Value

View PLXS Analysis

See Change In Receivables data for all stocks →